Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis

Journal of Cardiovascular Electrophysiology

Volumn 26, Issue 8, 2015, Pages 900-904

  El Chami, Mikhael F ^a   Levy, Mathew ^b   Kelli, Heval M ^a   Casey, Mary ^b   Hoskins, Michael H ^a   Goyal, Abhinav ^a   Langberg, Jonathan J ^a   Patel, Anshul ^a   DeLurgio, David ^a   Lloyd, Michael S ^a   Leon, Angel R ^a   Merchant, Faisal M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

dialysis; end stage renal disease; implantable cardioverter defibrillator; subcutaneous ICD; sudden cardiac death

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DEATH; DEFIBRILLATION; DEVICE FAILURE; DEVICE INFECTION; DEVICE REMOVAL; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SHOCK; T WAVE; ADVERSE EFFECTS; AGED; CARDIOMYOPATHIES; CARDIOVERSION; COMPLICATION; DEATH, SUDDEN, CARDIAC; DEVICES; GEORGIA; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RENAL REPLACEMENT THERAPY; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; GEORGIA; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RENAL DIALYSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84938210129     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12705     Document Type: Article

References (19)

1. Pun PH, Hellkamp AS, Sanders GD, Middleton JP, Hammill SC, Al-Khalidi HR, Curtis LH, Fonarow GC, Al-Khatib SM,: Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: A matched cohort study. Nephrol Dial Transplant: Official publication of the European Dialysis and Transplant Association-European Renal Association 2014.
2. Aggarwal A, Wang Y, Rumsfeld JS, Curtis JP, Heidenreich PA,: Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm 2009; 6: 1565-1571.
3. Hreybe H, Razak E, Saba S,: Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2007; 30: 1091-1095.
4. Hickson LJ, Gooden JY, Le KY, Baddour LM, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Sohail MR,: Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients. Am J Kidney Dis 2014; 64: 104-110.
5. Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, Winkelmayer WC,: Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 2011; 58: 409-417.
6. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA,: An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010; 363: 36-44.
7. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC,: Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013; 128: 944-953.
8. Gold MR, Weiss R, Theuns DA, Smith W, Leon A, Knight BP, Carter N, Husby M, Burke MC,: Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 2014; 11: 1352-1358.
9. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial III: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
10. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,; Sudden Cardiac Death in Heart Failure Trial I: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
11. Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kaab S, Murgatroyd F, Reeve HL, Carter N, Boersma L,;, Investigators E,: Worldwide experience with a totally subcutaneous implantable defibrillator: Early results from the EFFORTLESS S-ICD Registry. Eur Heart J 2014; 35: 1657-1665.
12. Jarman JW, Todd DM,: United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: Important lessons to learn. Europace 2013; 15: 1158-1165.
13. Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE,: The entirely subcutaneous implantable cardioverter-defibrillator: Initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 2012; 60: 1933-1939.
14. Aziz S, Leon AR, El-Chami MF,: The subcutaneous defibrillator: A review of the literature. J Am Coll Cardiol 2014; 63: 1473-1479.
15. Rowley CP, Gold MR,: Subcutaneous implantable cardioverter defibrillator. Circ Arrhythm Electrophysiol 2012; 5: 587-593.
16. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL,: Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: Results from the NCDR. Circulation 2013; 6: 488-497.
17. Olde Nordkamp LR, Warnaars JL, Kooiman KM, de Groot JR, Rosenmoller BR, Wilde AA, Knops RE,: Which patients are not suitable for a subcutaneous ICD: Incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol 2014; 25: 494-499.
18. Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ,: How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace 2014; 16: 1015-1021.
19. Brisben AJ, Burke MC, Knight BP, Hahn SJ, Herrmann KL, Allavatam V, Mahajan D, Sanghera R, Gold MR,: A new algorithm to reduce inappropriate therapy in the S-ICD system. J Cardiovasc Electrophysiol 2015; 26: 417-423.